Grading The Life Science Community's Pandemic Performance
Source: Bioprocess Online
From an A-minus to an “incomplete,” Heat Biologics Founder & CEO Jeff Wolf, Massachusetts Biomedical Initiatives President & CEO Jon Weaver, and Lakes BioScience Chief Strategy and Technology Officer Adrian Wallis share their perspectives on the performance of the public and private life sciences partnerships that led our global response to the COVID-19 pandemic in this segment of the BioProcess Online Live event The Next Pandemic: Biopharma's Opportunities and Obligations.
View the full presentation on-demand here.
This website uses cookies to ensure you get the best experience on our website. Learn more